DNTH Financials

Dianthus Therapeutics Inc. - Financial statements & key metrics

Stock Price

$106.62

Market Cap

$4.40B

P/E Ratio

-41.8

EPS

$-2.55

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$6.24M

Gross Profit

Operating Income

Net Income

$-84.97M

EPS (Diluted)

$-2.55

Profitability Metrics

Net Margin

-1362.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is DNTH revenue?

DNTH's most recent quarterly revenue was $6.24M. Annual revenue can be calculated by summing the four most recent quarters.

Is DNTH profitable?

DNTH reported a loss of $84.97M in the most recent quarter. The net profit margin is -1362.8%.

What is DNTH market cap?

DNTH has a market capitalization of $4.40B, making it a mid-cap stock.

Does DNTH have debt?

View DNTH's balance sheet for debt information.

What is DNTH cash flow?

Cash flow data is available in the full financial statements.